| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +7.01% | +0.35% | +6.66% | +6.66% | — |
| 14d | 1 | +0.00% | -5.73% | +4.21% | -9.95% | -9.95% | — |
| 30d | 1 | +0.00% | -24.20% | +7.58% | -31.78% | -31.78% | — |
| 60d | 1 | +100.00% | +63.06% | +14.32% | +48.74% | +48.74% | — |
| 90d | 1 | +100.00% | +61.78% | +18.96% | +42.82% | +42.82% | — |
| 180d | 1 | +100.00% | +4.78% | +27.55% | -22.78% | -22.78% | — |
| 1y | 1 | +0.00% | -58.92% | +29.52% | -88.44% | -88.44% | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| HUMA HUMACYTE, INC. | SALE10b5-1 10b5-1 plan | 45,887 | $0.90 | $41.1K | 272,713 | May 18, 2026 | May 20, 2026 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 311,100 | — | — | 318,600 | Nov 16, 2025 | Nov 17, 2025 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASE Chief Medical Officer | 7,500 | $1.55 | $11.6K | 7,500 | Apr 10, 2025 | Apr 14, 2025 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 283,101 | — | — | 283,101 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 283,000 | — | — | 283,000 | Dec 8, 2023 | Dec 12, 2023 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 91,120 | — | — | 91,120 | Dec 8, 2022 | Dec 12, 2022 ↗ | View → |
| HUMA HUMACYTE, INC. | PURCHASEGRANT Stock grant | 144,927 | — | — | 144,927 | Apr 4, 2022 | Apr 5, 2022 ↗ | View → |